22 results on '"Duan, Maosheng"'
Search Results
2. Double Counting of Emission Reductions Undermines the Credibility of Corporate Mitigation Claims
3. EXPERIENCE WITH CARBON TAXES AND GREENHOUSE GAS EMISSIONS TRADING SYSTEMS.
4. Interactions and coordination between carbon emissions trading and other direct carbon mitigation policies in China
5. A MODEL INTERCOMPARISON OF THE WELFARE EFFECTS OF REGIONAL COALITIONS FOR AMBITIOUS CLIMATE MITIGATION TARGETS
6. Key Issues in Allowance Allocation in China's Future Unified National Emissions Trading Scheme.
7. Novel Spiroketal PyrrolidineGSK2336805 Potently InhibitsKey Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound.
8. Linking China’s emissions trading pilot schemes
9. Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants.
10. Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile.
11. The new CORSIA baseline has limited motivation to promote the green recovery of global aviation.
12. Integrating more renewable electricity into the power system may increase carbon emissions
13. Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*
14. Enantioselective Total Synthesis of the Cyclophilin-Binding Immunosuppressive Agent Sanglifehrin AThis work was financially supported by Eli Lilly and Company and a Robert Mayer Graduate Fellowship (to M.D.). We thank Prof. K. C. Nicolaou for providing authentic spectra of 1.
15. Enantioselective Total Synthesis of the Cyclophilin-Binding Immunosuppressive Agent Sanglifehrin AThis work was financially supported by Eli Lilly and Company and a Robert Mayer Graduate Fellowship (to M.D.). We thank Prof. K. C. Nicolaou for providing authentic spectra of 1.
16. Enantioselective Total Synthesis of the Cyclophilin-Binding Immunosuppressive Agent Sanglifehrin A<FNR HREF="fnxx"></FNR> <FN ID="fnxx"> This work was financially supported by Eli Lilly and Company and a Robert Mayer Graduate Fellowship (to M.D.). We thank Prof. K. C. Nicolaou for providing authentic spectra of 1.</FN>
17. Synthesis of the tripeptide (C1–N12) and hydroxylated hexadecene (C26–C41) domains of sanglifehrin A and C
18. ChemInform Abstract: Discovery of a Novel Series of Cyclic Urea as Potent CCR5 Antagonists.
19. ChemInform Abstract: A Convergent Three‐Component Total Synthesis of the Powerful Immunosuppressant (‐)‐Sanglifehrin A.
20. ChemInform Abstract: Enantioselective Total Synthesis of the Cyclophilin‐Binding Immunosuppressive Agent Sanglifehrin A.
21. ChemInform Abstract: Highly Diastereocontrolled Synthesis of the C1—C25 Domain of Sanglifehrin A.
22. ChemInform Abstract: Synthesis of the Tripeptide (C1—N12) and Hydroxylated Hexadecene (C26—C41) Domains of Sanglifehrin A and C.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.